Bentham Science Publishers · United Arab Emirates · Est. 2005
ISSN1875-6662
SJR Q4✓ Scopus / SJR
5
/ 100
High Risk
Score Breakdown
✓ Scopus Q4+5
Total5
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.
SJR Score
0.168
H-Index
23
SNIP
0.138
Total Works
539
Total Citations
2,755
2yr Mean Citedness
0.24
Free JIF alternative
Aims & Scope✦ Inferred from recent articles
This journal publishes research on the design, synthesis, and evaluation of novel compounds as inhibitors for various enzymes and biological targets, including those relevant to neurodegenerative diseases, diabetes, cancer, and infectious diseases. Studies often employ computational methods like molecular docking and QSAR, alongside in vitro and in vivo experimental validation.
AI-summarised from recent articles · verify on the publisher page
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
BiochemistryQ4
Drug DiscoveryQ4
Molecular MedicineQ4
Subject Classification
Scopus Categories
Drug DiscoveryBiochemistryMolecular Medicine
Research Topics (OpenAlex)
Synthesis and biological activityComputational Drug Discovery MethodsNatural Antidiabetic Agents StudiesCholinesterase and Neurodegenerative DiseasesDiverse Scientific and Economic StudiesPhytochemicals and Antioxidant ActivitiesEnzyme function and inhibitionNitric Oxide and Endothelin EffectsEnzyme Production and CharacterizationCancer Mechanisms and Therapy